Viruses (Jul 2023)

Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication

  • Abhishek Asthana,
  • Angela Corona,
  • Woo-Jin Shin,
  • Mi-Jeong Kwak,
  • Christina Gaughan,
  • Enzo Tramontano,
  • Jae U. Jung,
  • Rainer Schobert,
  • Babal Kant Jha,
  • Robert H. Silverman,
  • Bernhard Biersack

DOI
https://doi.org/10.3390/v15071539
Journal volume & issue
Vol. 15, no. 7
p. 1539

Abstract

Read online

Viral replication often depends on RNA maturation and degradation processes catalyzed by viral ribonucleases, which are therefore candidate targets for antiviral drugs. Here, we synthesized and studied the antiviral properties of a novel nitrocatechol compound (1c) and other analogs that are structurally related to the catechol derivative dynasore. Interestingly, compound 1c strongly inhibited two DEDD box viral ribonucleases, HIV-1 RNase H and SARS-CoV-2 nsp14 3′-to-5′ exoribonuclease (ExoN). While 1c inhibited SARS-CoV-2 ExoN activity, it did not interfere with the mRNA methyltransferase activity of nsp14. In silico molecular docking placed compound 1c in the catalytic pocket of the ExoN domain of nsp14. Finally, 1c inhibited SARS-CoV-2 replication but had no toxicity to human lung adenocarcinoma cells. Given its simple chemical synthesis from easily available starting materials, these results suggest that 1c might be a lead compound for the design of new antiviral compounds that target coronavirus nsp14 ExoN and other viral ribonucleases.

Keywords